Compositions and methods for treating cancer
US11578136B2 · kind B2 · utility
1Cited by
31References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Feb 14, 2023 |
| Priority date | — |
| Expiry date | Feb 10, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antigen-binding compounds that inhibit the enzymatic activity of soluble human CD39. The invention also relates to cells producing such compounds; methods of making such compounds, and antibodies, fragments, variants, and derivatives thereof; pharmaceutical compositions comprising the same; methods of using the compounds to diagnose, treat or prevent diseases, e.g., cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.